相关实验视频

Updated: Mar 1, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

异形性肺纤维化:一个概述

James May¹, Gisli Jenkins¹

¹Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, SW3 6LY London, UK.

British journal of hospital medicine (London, England : 2005)

|February 28, 2026

概括

异形性肺纤维化 (IPF) 是一种进展性肺病,治疗方法有限. 研究旨在改善IPF的理解和管理,为更好的治疗和患者结果提供希望.

科学领域:

肺病学和呼吸系统医学
纤维性疾病的病理生物学
翻译医学是一种翻译医学.

背景情况:

异形性肺纤维化 (IPF) 是一种渐进的间歇性肺病,发病率不断上升,预后不佳.
目前IPF的治疗方法只能减缓疾病的进展,这凸显了大量未满足的医疗需求.
肺移植为IPF患者的生存和生活质量提供了唯一可观的改善.

研究的目的:

为提供关于异形性肺纤维化 (IPF) 的全面概述.
总结有关IPF定义,流行病学,病理生物学,诊断和管理策略的当前知识.
突出现有疗法的局限性和需要新疗法的需要.

主要方法:

文献综述和对IPF现有研究的综合.
对流行病学数据和疾病发病率趋势的分析.
目前IPF的诊断标准和管理指南的摘要.

主要成果:

IPF的特点是无情的进展,导致衰弱性呼吸不良和呼吸衰竭.
诊断后平均存活时间为3-5年,这突显了疾病的严重程度.
尽管在了解IPF病理生物学方面取得了进展,但治疗选择仍然有限.

结论:

迫切需要治疗方法来阻止或逆转IPF中的纤维化.
对新的治疗方法的持续研究表明,改善IPF结果是有前途的.
对IPF的全面理解对于推进诊断和管理策略至关重要.

关键词:

诊断诊断诊断诊断诊断诊断异形性肺纤维化异形性肺纤维化管理的管理管理的管理.结果就是结果.有关风险因素的风险因素.

更多相关视频

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis

Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis

Published on: May 23, 2025

相关概念视频

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Cystic Fibrosis: Pathogenesis

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...